Protocol for an implementation study of an evidence-based home cardiac rehabilitation programme for people with heart failure and their caregivers in Scotland (SCOT:REACH-HF).
cardiology
heart failure
rehabilitation medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
04 12 2020
04 12 2020
Historique:
entrez:
5
12
2020
pubmed:
6
12
2020
medline:
4
3
2021
Statut:
epublish
Résumé
Despite evidence that cardiac rehabilitation (CR) is an essential component of care for people with heart failure, uptake is low. A centre-based format is a known barrier, suggesting that home-based programmes might improve accessibility. The aim of SCOT: Rehabilitation EnAblement in CHronic Heart Failure (REACH-HF) is to assess the implementation of the REACH-HF home-based CR intervention in the context of the National Health Service (NHS) in Scotland.This paper presents the design and protocol for this observational implementation study. Specific objectives of SCOT:REACH-HF are to: (1) assess service-level facilitators and barriers to the implementation of REACH-HF; (2) compare real-world patient and caregiver outcomes to those seen in a prior clinical trial; and (3) estimate the economic (health and social) impact of implementing REACH-HF in Scotland. The REACH-HF intervention will be delivered in partnership with four 'Beacon sites' across six NHS Scotland Health Boards, covering rural and urban areas. Health professionals from each site will be trained to facilitate delivery of the 12-week programme to 140 people with heart failure and their caregivers. Patient and caregiver outcomes will be assessed at baseline and 4-month follow-up. Assessments include the Minnesota Living with Heart Failure Questionnaire (MLHFQ), five-dimension EuroQol 5L, Hospital Anxiety and Depression Scale, and the Caregiver Burden Questionnaire. Qualitative interviews will be conducted with up to 20 health professionals involved in programme delivery (eg, cardiac nurses, physiotherapists). 65 facilitator-patient consultations will be audio recorded and assessed for fidelity. Integrative analysis will address key research questions on fidelity, context and CR participant-related outcomes. The SCOT:REACH-HF findings will inform the future potential roll-out of REACH-HF in Scotland. The study has been given ethical approval by the West of Scotland Research Ethics Service (reference 20/WS/0038, approved 25 March 2020). Written informed consent will be obtained from all participants. The study is listed on the ISRCTN registry with study ID ISRCTN53784122. The research team will ensure that the study is conducted in accordance with both General Data Protection Regulations and the University of Glasgow's Research Governance Framework. Findings will be reported to the funder and shared with Beacon Sites, to facilitate service evaluation, planning and good practice. To broaden interest in, and understanding of REACH-HF, we will seek to publish in peer-reviewed scientific journals and present at stakeholder events, national and international conferences.
Identifiants
pubmed: 33277287
pii: bmjopen-2020-040771
doi: 10.1136/bmjopen-2020-040771
pmc: PMC7722379
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e040771Subventions
Organisme : Chief Scientist Office
ID : SPHSU14
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_13027
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU16
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/14
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00022/1
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Cochrane Database Syst Rev. 2019 Jan 29;1:CD003331
pubmed: 30695817
J Am Coll Cardiol. 2019 Apr 2;73(12):1430-1443
pubmed: 30922474
Eur J Heart Fail. 2017 Sep;19(9):1095-1104
pubmed: 28470962
Lancet. 2015 Feb 28;385(9970):812-24
pubmed: 25467564
J Adv Nurs. 2015 Nov;71(11):2478-89
pubmed: 26084885
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Yearb Med Inform. 2000;(1):65-70
pubmed: 27699347
Pilot Feasibility Stud. 2016 Aug 2;2:37
pubmed: 27965855
BMJ. 2015 Sep 29;351:h5000
pubmed: 26419744
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
Milbank Q. 2007;85(1):93-138
pubmed: 17319808
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Int J Cardiol. 2014 Feb 15;171(3):368-76
pubmed: 24398230
Cochrane Database Syst Rev. 2019 Feb 01;2:CD007131
pubmed: 30706942
BMJ. 2004 Jun 26;328(7455):1561-3
pubmed: 15217878
BMJ Open. 2020 Jun 21;10(6):e036137
pubmed: 32565467
Annu Rev Public Health. 2010;31:399-418
pubmed: 20070207
Eur J Prev Cardiol. 2019 Aug;26(12):1252-1261
pubmed: 30884975
Implement Sci. 2018 Jun 7;13(1):80
pubmed: 29879986
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72
pubmed: 14960256
Eur J Prev Cardiol. 2019 Feb;26(3):262-272
pubmed: 30304644